149 related articles for article (PubMed ID: 32730784)
1. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Palayew A; Razavi H; Hutchinson SJ; Cooke GS; Lazarus JV
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):948-953. PubMed ID: 32730784
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis.
Chaabna K; Kouyoumjian SP; Abu-Raddad LJ
PLoS One; 2016; 11(2):e0149966. PubMed ID: 26900839
[TBL] [Abstract][Full Text] [Related]
3. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women.
Elsheikh RM; Daak AA; Elsheikh MA; Karsany MS; Adam I
Virol J; 2007 Oct; 4():104. PubMed ID: 17958904
[TBL] [Abstract][Full Text] [Related]
5. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.
Seed CR; Cheng A; Ismay SL; Bolton WV; Kiely P; Cobain TJ; Keller AJ;
Transfusion; 2002 Oct; 42(10):1365-72. PubMed ID: 12423522
[TBL] [Abstract][Full Text] [Related]
6. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
Cooke GS; Andrieux-Meyer I; Applegate TL; Atun R; Burry JR; Cheinquer H; Dusheiko G; Feld JJ; Gore C; Griswold MG; Hamid S; Hellard ME; Hou J; Howell J; Jia J; Kravchenko N; Lazarus JV; Lemoine M; Lesi OA; Maistat L; McMahon BJ; Razavi H; Roberts T; Simmons B; Sonderup MW; Spearman CW; Taylor BE; Thomas DL; Waked I; Ward JW; Wiktor SZ;
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):135-184. PubMed ID: 30647010
[TBL] [Abstract][Full Text] [Related]
7. The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data.
Palayew A; Stumo SR; Cooke GS; Hutchinson SJ; Jauffret-Roustide M; Maticic M; Harris M; Metwally AM; Razavi H; Lazarus JV;
PLoS One; 2020; 15(7):e0235715. PubMed ID: 32722701
[TBL] [Abstract][Full Text] [Related]
8. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
[TBL] [Abstract][Full Text] [Related]
9. Why is hepatocellular carcinoma less attributable to viral hepatitis in Yemen?
Saeed NM; Bawazir AA; Al-Zuraiqi M; Al-Negri F; Yunus F
Asian Pac J Cancer Prev; 2012; 13(8):3663-7. PubMed ID: 23098451
[TBL] [Abstract][Full Text] [Related]
10. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
[TBL] [Abstract][Full Text] [Related]
11. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
Ward JW; Hinman AR
Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and hepatitis C virus infections in United States-bound refugees from Asia and Africa.
Mixson-Hayden T; Lee D; Ganova-Raeva L; Drobeniuc J; Stauffer WM; Teshale E; Kamili S
Am J Trop Med Hyg; 2014 Jun; 90(6):1014-20. PubMed ID: 24732462
[TBL] [Abstract][Full Text] [Related]
14. Barriers and Strategies for Hepatitis B and C Elimination in Pakistan.
Qureshi H; Mahmood H; Sabry A; Hermez J
J Infect Dis; 2023 Sep; 228(Suppl 3):S204-S210. PubMed ID: 37703344
[TBL] [Abstract][Full Text] [Related]
15. HBV and HCV infections in heart transplant recipients.
Fagiuoli S; Minniti F; Pevere S; Farinati F; Burra P; Livi U; Naccarato R; Chiaramonte M
J Heart Lung Transplant; 2001 Jul; 20(7):718-24. PubMed ID: 11448796
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina.
Pereson MJ; Martínez AP; Isaac K; Laham G; Ridruejo E; Garcia GH; Flichman DM; Di Lello FA
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33180017
[No Abstract] [Full Text] [Related]
17. Epidemiology of hepatitis B and C virus infection in Central West Argentina.
Villar LM; de Paula VS; do Lago BV; Miguel JC; Cruz HM; Portilho MM; Marques VA; Ravier RP; Lo Castro I; Cuello H; Espul C
Arch Virol; 2020 Apr; 165(4):913-922. PubMed ID: 32078045
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B virus and hepatitis C virus in health workers in 3 major hospitals in Aden, Republic of Yemen.
Al-Jarba AS; Al-Sayyari WM
Saudi Med J; 2003 Sep; 24(9):1031-2. PubMed ID: 12973499
[No Abstract] [Full Text] [Related]
19. High Rates of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus Infections and Uncommon HBV Genotype/Subtype and HCV Subtype Distributions among Transgender Individuals in Surabaya, Indonesia.
Hadikusumo AA; Utsumi T; Amin M; Khairunisa SQ; Istimagfirah A; Wahyuni RM; Lusida MI; Soetjipto ; Rianto E; Juniastuti ; Hayashi Y
Jpn J Infect Dis; 2016 Nov; 69(6):493-499. PubMed ID: 27000450
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of HBV and HCV markers among patients attending the Saint Camille Medical Centre in Ouagadougou.
Zeba MT; Ouattara CA; Karou SD; Bisseye C; Ouermi D; Djigma FW; Sagna T; Pietra V; Moret R; Nikiema J; Simpore J
Pak J Biol Sci; 2012 May; 15(10):484-9. PubMed ID: 24187903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
